The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.

Meniere's disease (MD) is a medical condition causing attacks of vertigo, ringing in the ears, hearing loss and often a fullness in the ear. Currently there is no definitive test to diagnose the problem. It is believed to be caused by inner ear abnormalities, specifically of an over-collection of lymphatic fluid.The goal of this trial is to determine if an MRI with double dose of IV gadolinium can be diagnostic.

Inclusion Criteria:

• Diagnosis of unilateral Meniere Disease (MD) per the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
• Glomerular filtration rate (GFR) > 90 mls/min/1.73 m2
• Creatinine (Cr) level serum < 1.6 mg/dl

Exclusion Criteria:

• Age < 18 years
• Diagnosis of bilateral MD
• History of prior temporal bone surgery
• History of cochlear implant placement
• Pacemaker, cardiac implantable electronic device, shrapnel, aneurysm clips or other metal objects that are prohibited in the MR suite
• GFR < 90 mls/min/1.73m2
• Cr level > 1.6 mg/d
• Lack of IV access
• Contrast allergy to gadolinium agent
• Pregnancy
• Claustrophobia necessitating parenteral anxiolytics
• Patients who are unable to provide informed consent for themselves